Focus: Route 92 Medical is a public medical device company specializing in catheter technology for neurovascular intervention, with a focused pipeline in acute ischemic stroke treatment.
Profile data last refreshed 11h ago · AI intelligence enriched 3w ago
Cooling — net -5 jobs in 30d
3 added, 8 removed. Slower than typical.
Route 92 Medical is a specialized, capital-backed device company ideal for specialists seeking early commercialization impact in neurovascular stroke intervention, but carries execution risk typical of small public medtech firms.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Route 92 Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Route 92 Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Myriad to sell prenatal health testing business to Labcorp - Medical Buyer
Myriad to sell prenatal health testing business to Labcorp Medical Buyer
Route 92 lands $100M debt facility from Trinity Capital to scale stroke platform - Dealroom
Route 92 lands $100M debt facility from Trinity Capital to scale stroke platform Dealroom
Route 92 Medical Announces $100 Million Corporate Debt Facility - GlobeNewswire
Route 92 Medical Announces $100 Million Corporate Debt Facility GlobeNewswire
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4 - Yahoo Finance
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4 Yahoo Finance
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4 - GlobeNewswire
Route 92 Medical Announces U.S. FDA Clearance for the FreeClimb® 46 Catheter with Tenzing® 4 GlobeNewswire
Boston Scientific halts sales of angiographic catheters amid 2 serious injuries - Fierce Biotech
Boston Scientific halts sales of angiographic catheters amid 2 serious injuries Fierce Biotech
Showing 6 of 10 news items
Based on last 4 crawl cycles
Recent peer-reviewed publications with author affiliations at this company
The novel Tenzing 7 delivery catheter designed to deliver intermediate catheters to the face of embolus without crossing: clinical performance predicted in anatomically challenging model.
Preventing vessel perforations in endovascular thrombectomy: feasibility and safety of passing the clot with a microcatheter without microwire: the wireless microcatheter technique.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo